ImmunoGen
Ventana, ImmunoGen Team up in CDx Deal
NEW YORK (GenomeWeb) – Roche's Ventana Medical Systems today announced a deal with ImmunoGen to develop an immunohistochemistry-based companion diagnostic test for the oncology therapeutic firm's product candidates.
Myriad, BioMarin Ink Deal to Use HRD Test to ID Responders to PARP Inhibitor
MDx/CDx Focus: Genomind's New Portal for Physicians; Overseas Regulators Positive on Kadcyla
Premium
Genomind Introduces Physician Portal for Genecept Results
FDA Approves Genentech's Antibody-Drug Conjugate, Marking Third Rx for HER2-Targeted Breast Cancer
Premium
The US Food and Drug Administration last week approved Roche/Genentech's latest HER2-targeting breast cancer drug, trastuzumab emtansine (T-DM1).
ADNI Researchers and Industry Partners Developing Proteomic Profiles to Track Alzheimer's Disease
Premium
Biotechnology firms participating in the Alzheimer's Disease Neuroimaging Initiative have received plasma and CSF samples from ADNI participants and contributed funds for the processing of roughly 1,000 samples by biomarker discovery firm Rules-Based Medicine.
Aug 20, 2009
People in the News: Aug 20, 2009
Premium
May 1, 2009